首页> 外国专利> The Activity of Kinase Inhibitors useful in the treatment of disorders mediated by mechanisms of ikk2

The Activity of Kinase Inhibitors useful in the treatment of disorders mediated by mechanisms of ikk2

机译:激酶抑制剂的活性可用于治疗由ikk2机制介导的疾病

摘要

The compounds are inhibitors of this kinase activity, particularly the activity of ikk2.Claim 1: a compound according to formula (1): wherein R1 is - or - so2nr3r4 nr5so2ch3, R2 is chr6r7 Cf3 -, - or - C (CH3) 3; R3 is Hydrogen or Methyl and R4 is Hydrogen, alkyl, optionally substituted with hydroxyl C1 - 6, - (CH2) acicloalquilo C3 6, which is optionally substituted cycloalkyl Mind with hydroxyl or - NH2, - (CH2) bnr8r9 optionally substituted alkyl, piperidinilo C1 - 6Formula (2), R3 and R4 are United to form pirrolidinilo, or optionally substituted with - NH2 piperidinilo; R5 is Hydrogen or Methyl; R6 and R7 is Hydrogen Hydrogen, alkyl C1 - 6, - (CH2) dor10, nr11r12 - alkyl -, CO2 - C1 - 6, - conr13r14 phenyl,Five members or heteroaryl containing from one to four nitrogen Atoms in the heteroaryl is optionally substituted with one or two alkyl substituents selected regardless of C1 - 6 - CO alkyl C1 - 6, - (CH2) efenilo and tienilo, R6 and R7 are each fluor, R6 is met ILO and r7es Methyl and hydroxylOr R6 and R7 are United to form a cycloalkyl, optionally substituted with Methyl C3 - 6; R9 R8 is Hydrogen; C1 is Hydrogen, alkyl or alkyl - 6 - CO2 - C1 - 6; R10 is Hydrogen, phenyl optionally substituted with - (CH2) fco2r15 piridilo, or optionally substituted with one or two substituents SEL Eccionados Rent regardless of chlorine and Hydrogen is C1 - 6; R11 and R12 is Hydrogen,- (CH2) gnr16r17 HNCO, - (CH2) - alkyl C1 - 6, - (CH2) icicloalquilo C3 - 6, - (CH2) jfeniio, - (CH2) kpiridilo, or mheterociclilo - (CH2), in which the heterociclilo is optionally substituted alkyl C1 - 6, R11 is C1 - Rent 6 and R12 is C1 - 6 or - alkyl so2fenilo, R11 and R12 are United to form a Het Erociclilo 6-membered optionally containing one nitrogenIn the heterociclilo is optionally substituted with alkyl - CO2 - C1 - 6 or piperidinilo, R11 and R12 or are United to form formula (3); R13 and R14 is H is H, alkyl C1 - 6, - (CH2) nor18, - (CH2) pnr19r20, - (CH2) qco2r21, - (CH2) rso2nh2 c3-6, cycloalkyl, optionally substituted phenyl or with C Parrot or alkyl - or - C1 - 6, R13 and R14 are each independently alkyl C1 - 6Or R13 and R14 are United to form pirrolidinilo; R15, R17, R16, R18, R19, R20 R21 and are each independently Hydrogen or alkyl of C1 - 6, a, D, e, F, I, J, K and M are each independently selected an integer from 0 to 4; b g, h, N, P, Q and R are each independently You selected an integer from 1 to 4; and C is 0 OR 1; or a Salt thereof.
机译:所述化合物是该激酶活性,尤其是ikk2活性的抑制剂。权利要求1:根据式(1)的化合物:其中R1是-或-so2nr3r4nr5so2ch3,R2是chr6r7 Cf3-,-或-C(CH3)3 ; R 3是氢或甲基,并且R 4是氢,烷基,任选地被羟基C 1-6取代,-(CH 2)环氯基C 3 6,其是任选地被羟基或-NH 2取代的环烷基,-(CH 2)bnr8r9任选地被取代的烷基,哌啶子基C1-6式(2),R3和R4被结合形成吡咯烷基,或任选地被-NH2哌啶子基取代; R5是氢或甲基; R6和R7是氢,氢,烷基C1-6,-(CH2)dor10,nr11r12-烷基-,CO2-C1-6,-conr13r14苯基,含1-4个氮的五元或杂芳基杂芳基中的原子是任选取代的带有一个或两个烷基取代基的取代基,而不考虑C1-6-CO烷基C1-6,-(CH2)苯芬洛和蒂尼洛,R6和R7均为氟,R6被ILO和r7es甲基和羟基或R6和R7结合形成任选被甲基C 3-6取代的环烷基; R9 R8是氢; C1是氢,烷基或烷基-6-CO2-C1-6; R10是氢,苯基任选地被-(CH2)fco2r15 piridilo取代,或任选地被一个或两个取代基取代,而与氯无关,并且氢是C1-6。 R11和R12是氢,-(CH2)gnr16r17 HNCO,-(CH2)-烷基C1-6,-(CH2)二氯代喹啉C3-6,-(CH2)苯丙胺基,-(CH2)哌啶子基或甲基-(CH2) ,其中杂环基是任选取代的烷基C 1-6,R 11是C 1 -Rent 6,并且R 12是C 1-6或-烷基so2fenilo,R 11和R 12结合形成Het Erociclilo 6元,任选地包含一个氮。任选地被烷基-CO 2 -C 1-6或哌啶子基,R 11和R 12取代或被结合以形成式(3); R 13和R 14为H为H,烷基C1-6,-(CH2)nor18,-(CH2)pnr19r20,-(CH2)qco2r21,-(CH2)rso2nh2 c3-6,环烷基,任选取代的苯基或与C烷基-或-C1-6,R13和R14各自独立地为烷基C1-6或R13和R14结合形成吡咯烷基。 R 15,R 17,R 16,R 18,R 19,R 20 R 21和R 15各自独立地为氢或C 1-6的烷基,a,D,e,F,I,J,K和M各自独立地选自0至4的整数; b g,h,N,P,Q和R分别独立地选择1到4之间的整数; C为0或1;或其盐。

著录项

  • 公开/公告号AR062928A1

    专利类型

  • 公开/公告日2008-12-17

    原文格式PDF

  • 申请/专利权人 GLAXO GROUP LIMITED;

    申请/专利号AR2007P104169

  • 发明设计人

    申请日2007-09-20

  • 分类号C07D471/04;A61K31/4353;A61P19/02;

  • 国家 AR

  • 入库时间 2022-08-21 19:28:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号